These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 369364)

  • 1. Empiric therapy of febrile granulocytopenic patients.
    Hopefl AW
    Am J Hosp Pharm; 1979 Feb; 36(2):178-87. PubMed ID: 369364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
    Walsh TJ; Schimpff SC
    Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
    Klastersky J; Zinner SH; Calandra T; Gaya H; Glauser MP; Meunier F; Rossi M; Schimpff SC; Tattersall M; Viscoli C
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S35-45. PubMed ID: 3280326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. A report of the EORTC International Antimicrobial Therapy Project Group.
    Gaya H
    Schweiz Med Wochenschr Suppl; 1983; 14():49-57. PubMed ID: 6361992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical therapy in febrile granulocytopenic patients.
    Gaya H
    Eur J Cancer (1965); 1979; 15 Suppl():51-8. PubMed ID: 397061
    [No Abstract]   [Full Text] [Related]  

  • 9. New antibacterial agents: the role of new penicillins and cephalosporins in the management of infection in granulocytopenic patients.
    Klastersky J
    Clin Haematol; 1984 Oct; 13(3):587-98. PubMed ID: 6388934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
    Zinner SH; Dudley M; Blaser J
    Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of infection in patients with granulocytopenia.
    Schimpff SC
    Med Clin North Am; 1977 Sep; 61(5):1101-18. PubMed ID: 330973
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
    Klastersky J
    Arch Intern Med; 1982 Oct; 142(11):1984-7. PubMed ID: 6215007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of febrile episodes in-neutropenic cancer.
    Bishop JF; McLennan R; Whiteside MG
    Med J Aust; 1977 Apr; 1(14):473-5. PubMed ID: 865367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients.
    Gaya H
    Clin Haematol; 1984 Oct; 13(3):573-86. PubMed ID: 6388933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
    De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
    Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.
    Schimpff SC; Gaya H; Klastersky J; Tattersall MH; Zinner SH
    J Infect Dis; 1978 Jan; 137(1):14-29. PubMed ID: 624850
    [No Abstract]   [Full Text] [Related]  

  • 19. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients.
    Winston DJ; Ho WG; Young LS; Hewitt WL; Gale RP
    Arch Intern Med; 1982 Sep; 142(9):1663-7. PubMed ID: 6214228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Netilmicin in the treatment of infections in patients with cancer.
    Yap BS; Bodney GP
    Arch Intern Med; 1979 Nov; 139(11):1259-62. PubMed ID: 389189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.